Sign in

CIK 0001636282 · Large accelerated filer

Spyre Therapeutics, Inc.

Sign in to watch
Ticker
SYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464312787
Phone
6176515940
Business address
221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
Aeglea BioTherapeutics, Inc.
  1. 4 Insider Changes in Ownership
  2. 4 Insider Changes in Ownership
  3. 4 Insider Changes in Ownership
  4. SC 13G/A Stake Amended Statement of Ownership
  5. SC 13G/A Stake Amended Statement of Ownership
  6. EFFECT Other Notice of Effectiveness
  7. 424B5 Offering Prospectus
  8. SC 13G/A Stake Amended Statement of Ownership
  9. SC 13G/A Stake Amended Statement of Ownership
  10. CORRESP Other Correspondence Between Filers and SEC Staff
  11. S-3/A Offering Registration Statement
  12. 4 Insider Changes in Ownership
  13. SC 13G Stake Amended Statement of Ownership
  14. 8-K Event Material agreement · Results of operations
  15. 424B5 Offering Prospectus
  16. 424B5 Offering Prospectus
  17. SC 13G/A Stake Amended Statement of Ownership
  18. UPLOAD Other SEC-generated Letter
  19. SC 13G/A Stake Amended Statement of Ownership
  20. SC 13G/A Stake Amended Statement of Ownership

Page 31 of 42 · 823 filings